TrialOrphanet journal of rare diseases2020

The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects.

Markus S Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.